S1PR1-DT: A Potential Drug Target and Biomarker (G101928370)

Target Name: S1PR1-DT

NCBI ID: G101928370

S1PR1-DT

Other Name(s): S1PR1 divergent transcript | LISPR1

S1PR1-DT: A Potential Drug Target and Biomarker

S1PR1, short for solute carrier subfamily 11, is a protein that plays a critical role in the transport of various molecules across cell membranes. It is composed of two subunits, S1PR1?± and S1PR1??, which are involved in the transport of different molecules, including drugs, toxins, and ions. The S1PR1 family is composed of various isoforms, including S1PR1-DT, which has been identified as a potential drug target and biomarker.

S1PR1-DT is a 21-kDa protein that is expressed in various tissues, including the brain, heart, liver, and pancreas. It is highly expressed in the brain, and its expression is decreased in the ageing process. S1PR1-DT has been shown to be involved in the transport of various molecules across cell membranes, including drugs.

One of the most significant findings related to S1PR1-DT is its involvement in drug transport. S1PR1-DT has been shown to be a drug transporter, which means that it can transport various drugs across cell membranes. This is important because drugs that are not transported across cell membranes cannot enter the cells and have little or no therapeutic effect. S1PR1-DT has been shown to transport a variety of drugs, including opioids, benzodiazepines, and statins.

S1PR1-DT has also been shown to play a role in the detoxification of drugs. Many drugs have a high affinity for S1PR1-DT, and it has been shown to transport these drugs across cell membranes and to protect them from elimination in the body. This is important because drugs that are not detoxified can have toxic effects on the body and can lead to chronic health problems. S1PR1-DT has been shown to protect drugs from elimination by transporting them across cell membranes and by modulating the expression of other genes involved in drug detoxification.

In addition to its role in drug transport and detoxification, S1PR1-DT has also been shown to be involved in the regulation of pain and inflammation. S1PR1-DT has been shown to play a role in the regulation of pain perception and neuroinflammation, and its expression is often decreased in individuals with chronic pain or neuroinflammation. S1PR1-DT has been shown to transport opioids across cell membranes and to modulate the expression of genes involved in pain perception and neuroinflammation.

S1PR1-DT has also been shown to be involved in the regulation of cell survival and proliferation. S1PR1-DT has been shown to play a role in the regulation of cell survival and proliferation by transporting nutrients and growth factors across cell membranes and by modulating the expression of genes involved in cell growth and survival.

In conclusion, S1PR1-DT is a protein that is involved in the transport of various molecules across cell membranes, including drugs. Its expression is often decreased in tissues with ageing, and it has been shown to play a role in drug transport, detoxification, pain and inflammation regulation, and cell survival and proliferation. As a result, S1PR1-DT is a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and chronic pain. Further research is needed to fully understand the role of S1PR1-DT in these diseases and to develop effective treatments.

Protein Name: S1PR1 Divergent Transcript

The "S1PR1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about S1PR1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets